|
Volumn 21, Issue 5, 2015, Pages S97-S105
|
Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--the new and evolving standards of care
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
COMBINATION DRUG THERAPY;
COST BENEFIT ANALYSIS;
ECONOMICS;
HEALTH CARE QUALITY;
HEALTH INSURANCE;
HEPATITIS C, CHRONIC;
HUMAN;
ANTIVIRAL AGENTS;
COST-BENEFIT ANALYSIS;
DRUG THERAPY, COMBINATION;
HEPATITIS C, CHRONIC;
HUMANS;
MANAGED CARE PROGRAMS;
STANDARD OF CARE;
|
EID: 85016924784
PISSN: None
EISSN: 19362692
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|